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We have read with interest the results of the survey by
Cnossen et al. [1], in which the authors affirm that substan-
tial variation was found regarding monitoring and treatment
policies in TBI patients and intracranial hypertension
among 66 European neurotrauma centers. We observe that
this result is no different from the conclusion of a similar
survey on blood transfusion and coagulation management
of TBI patients belonging to the same research group [2].
Moreover, these results agree with another survey on the
management of mild TBI patients [3]. The authors’ conclu-
sion shows that, even among high-volume specialized
neurotrauma centers, there is a substantial variation in
structures and processes of TBI care and a discrepancy be-
tween BTF guidelines and reported policies [1–3].
Although this variability between European neurotrauma
centers provides an opportunity to study the effectiveness
of specific aspects of TBI care and to identify best practices
with comparative effectiveness research, the lack of BTF
guideline application remains a concern. Compared to a
previous study from a decade ago, the data from Cnossen
et al. [1] show a reduction in application of the BTF guide-
lines to 49% and 51% in aggressive and conservative centers
respectively. The low adherence to guidelines may explain
the variability and heterogeneity of the treatment as we
reported recently in the neurointensive care setting of sub-
arachnoid hemorrhage patients due to cerebral aneurysm
rupture [4].
While it seems that neurointensivists do not follow the
rules, we do not have to forget that this phenomenon has
also occurred in other fields of medicine. Arts et al. [5] re-
ported in a recent systematic review that intentional non-
adherence to guidelines varied between 8.2 and 65.3%.
The same authors concluded that nonadherence is often
supported by valid reasons in up to 93.6%. Guideline devi-
ations are intentional, mainly related to contraindications
or due to the patient’s decision, and these deviations do
not necessarily impact on the quality of care [5].
However, none of the studies analyzed by Arts et al. [5]
was carried out in the neuro-ICU setting where the critical
situation of the patients, most of them unconscious, post-
pones any possible consensus decision. Moreover, therapy
contraindications disappear when a second-line life treat-
ment is requested. In the hardest of ICU settings, where
the patients ‘will disappear’, following guidelines seems to
assume a different meaning. We are confident that future
studies in the perspective of the CENTER-TBI study can
shed light on the actual role of guidelines and protocols in
the complex context of neuro-ICUs.
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considerable variation in monitoring and treatment pol-
icies in patients with TBI and intracranial hypertension
[1]. This variation probably reflects the lack of evidence
[6] and guideline adherence [7] for the treatment of pa-
tients with TBI.
Based on Table 1 in the original paper [1], Gritti and col-
leagues infer that, in comparison to a previous report,
guideline adherence to the BTF guidelines has been re-
duced to 49% and 51% in aggressive and conservative cen-
ters, respectively. This statement, however, is incorrect. Of
the total sample, the BTF guidelines were used in 49 (74%)
centers. Among these 49 centers, 25 (51%) could be
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classified as ‘aggressive’ and 24 (49%) as ‘conservative’ with
regard to ICP management.
Guideline adherence is higher for recommendations
based on more robust evidence than for recommendations
based on relatively weak evidence [7]. However, subsequent
editions of the BTF guidelines have progressively reduced
the strength of the recommendations, after reevaluation of
the weak evidence. We believe that strengthening the evi-
dence base will result in an improvement in guideline ad-
herence, and subsequently will reduce treatment variation.
Comparative effectiveness research (CER) provides a
promising framework for expanding our knowledge of
TBI treatment effectiveness. The CENTER-TBI study is
currently recruiting approximately 5000 patients from 20
European countries. Once these patient-level data become
available, the first step will be to compare the results of
the provider profiling questionnaires with the actually ob-
served treatment variation among centers. The next step
will be to examine the association between treatment and
outcome with CER approaches, to strengthen the evidence
underpinning TBI guidelines. A third step will be to de-
velop a tentative set of quality indicators for TBI, which
could potentially be used for benchmarking and quality
assurance of future TBI care.
As Sackett wrote, “Evidence based medicine is the
conscientious, explicit, and judicious use of current best
evidence in making decisions about the care of individ-
ual patient” [8].
As such, a set of rules to be blindly followed or to be
broken has never been proposed. We are confident that de-
tailed large data collection, advanced methodology, and glo-
bal collaboration with other projects (e.g., TRACK-TBI in
the United States) will provide better evidence for ground-
ing better treatments for TBI victims.
Abbreviation
TBI: Traumatic brain injury; BTF: Brain Trauma Foundation; CENTER-
TBI: Collaborative European Neurotrauma Effectiveness Research in Traumatic
Brain Injury; ICU: Intensive care unit
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